Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis
Nordstrom, D.
Journal of Rheumatology 22(5): 1000-1001
1995
ISSN/ISBN: 0315-162X PMID: 8587061 Document Number: 446702
Document emailed within 1 workday
Related Documents
Hedayati, H.; Zuzga, J.J.; Faber, D.B. 1993: Rheumatoid arthritis, relapsing polychondritis, and pyoderma gangrenosum evolving into non-Hodgkin's lymphoma Journal of the American Osteopathic Association 93(2): 240McGowan, J.W.; Johnson, C.A.; Lynn, A. 2004: Treatment of pyoderma gangrenosum with etanercept Journal of Drugs in Dermatology: Jdd 3(4): 441-444
Azizan, N.Z.; Gangaram, H.B.; Hussein, S.H. 2008: A novel therapy for the treatment of pyoderma gangrenosum Medical Journal of Malaysia 63(1): 51-54
Chan, J.L.; Graves, M.S.; Cockerell, C.J.; Pandya, A.G. 2010: Rapid improvement of pyoderma gangrenosum after treatment with infliximab Journal of Drugs in Dermatology: Jdd 9(6): 702-704
Bobbitt, S.A.; Klaus, E.M.; Stringer, E.; Chowdhury, D.; Finlayson, L. 2016: Treatment of refractory pyoderma gangrenosum with infliximab in a 17-month-old boy Dermatology Online Journal 22(4)
De Vita, S.; Neri, R.; Bombardieri, S. 1991: Cyclophosphamide pulses in the treatment of rheumatic diseases: an update Clinical and Experimental Rheumatology 9(2): 179-193
Handler, M.Z.; Hamilton, H.; Aires, D. 2011: Treatment of peristomal pyoderma gangrenosum with topical crushed dapsone Journal of Drugs in Dermatology: Jdd 10(9): 1059-1061
Din, R.S.; Tsiaras, W.G.; Li, D.G.; Mostaghimi, A. 2018: Efficacy of Systemic Dapsone Treatment for Pyoderma Gangrenosum: A Retrospective Review Journal of Drugs in Dermatology: Jdd 17(10): 1058-1060
De Vita, S.; Fossaluzza, V. 1992: Treatment of idiopathic inflammatory myopathies with cyclophosphamide pulses: clinical experience and a review of the literature Acta Neurologica Belgica 92(4): 215-227
Neiderer, K.; Martin, B.; Hoffman, S.; Jolley, D.; Dancho, J. 2012: A mechanically powered negative pressure device used in conjunction with a bioengineered cell-based product for the treatment of pyoderma gangrenosum: a case report Ostomy/Wound Management 58(9): 44-48
Neill, B.C..; Seger, E.W..; Hooton, T.A..; Bailey, G.; Rajpara, A.; Stoecker, W.V.. 2019: The 5 P's of Pyoderma Gangrenosum Journal of Drugs in Dermatology: Jdd 18(12): 1282-1283
Feuerman, E.; Potruch-Eisenkraft, S. 1971: The problem of pyoderma gangrenosum Harefuah 80(5): 251-254
El Fékih, N.; Kerkeni, N.; Kharfi, M.; Baccouche, D.; Zéglaoui, F.; Fazaa, B.; Kamoun Mohamed, R. 2010: Pyoderma gangrenosum: 6 cases Revue Medicale de Liege 65(9): 506-509
El-Kehdy, J.; Haneke, E.; Karam, P.G. 2013: Pyoderma gangrenosum: a misdiagnosis Journal of Drugs in Dermatology: Jdd 12(2): 228-230
Leger, M.; Newlove, T.; Chu, J.; Meehan, S.; Stein, J. 2011: Pustular pyoderma gangrenosum Dermatology Online Journal 17(10): 17
Allegue Rodriguez, F.; Marques Huberti, A.; Freire Murgueytio, P.; Ledo Pozueta, A. 1988: Peristomal pyoderma gangrenosum Annales de Dermatologie et de Venereologie 115(4): 485
Rubisz-Brzezinska, J.; Seferowicz, E.; Dabrowski, Z. 1971: Pyoderma gangrenosum (dermatitis ulcerosa) Przeglad Dermatologiczny 58(3): 317-323
Ljubojević, S.; Milavec-Puretić, V.; Sredoja-Tisma, V.; Rados, J.; Kalauz, M.; Hrstić, I. 2006: Pyoderma gangrenosum associated with ulcerative colitis Acta Dermatovenerologica Croatica: Adc 14(1): 35-39
Pawar, G.P.; Satija, V.K.; Pawar, B. 1987: Pyoderma gangrenosum in ulcerative colitis Journal of the Association of Physicians of India 35(6): 448-450
Zabel, M. 1976: Pyoderma gangrenosum with IgG-paraproteinemia in plasmacytoma Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 27(12): 603-605